Goldman Sachs
CELU icon

Goldman Sachs’s Celularity CELU Stock Holding History

Goldman Sachs’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,625
Closed -$72.6K – 5575
2023
Q2 		$72.6K Buy
13,625
+10,299
+310% +$66K ﹤0.01% 5411
2023
Q1 		$20.6K Sell
3,326
-1,804
-35% -$14.5K ﹤0.01% 5665
2022
Q4 		$66.2K Buy
5,130
+2,193
+75% +$40.4K ﹤0.01% 5562
2022
Q3 		$68K Buy
+2,937
New +$89.1K ﹤0.01% 5762
2022
Q2 		– Sell
-2,079
Closed -$181K – 6478
2022
Q1 		$181K Buy
+2,079
New +$125K ﹤0.01% 5922
2021
Q2 		– Sell
-10,000
Closed -$1.01M – 6218
2021
Q1 		$1.01M Buy
10,000
+3,000
+43% +$307K ﹤0.01% 4602
2020
Q4 		$770K Buy
7,000
+2,000
+40% +$213K ﹤0.01% 4365
2020
Q3 		$525K Buy
+5,000
New +$518K ﹤0.01% 4458

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs's CELU Position: Q3 2023 in Review

Goldman Sachs sold out of Celularity (CELU) in Q3 2023, closing a stake of 13,625 shares — an estimated $72.6K sold.

Goldman Sachs first reported a position in CELU in Q3 2020 and held it in 8 quarters. The position peaked at $1.01M in Q1 2021. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

  • Goldman Sachs reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 13,625 Celularity shares in Q3 2023, an estimated $72.6K.
  • Goldman Sachs first reported a position in Celularity in Q3 2020 and held it in 8 quarters.
  • Goldman Sachs's Celularity position peaked at $1.01M in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.